Completed NA INTERVENTIONAL 2-arm NCT00998023

Patient Comfort With Vascular Closure

Patient Comfort Study With Vascular Closure: Mynx vs. Angio-Seal Evolution

Sponsor: Access Pharmaceuticals, Inc.

Interventions AngioSeal Vascular Closure Device Mynx Vascular Closure Device

Updated 8 times since 2017 Last updated: Dec 5, 2011 Started: Oct 31, 2009 Primary completion: Jul 31, 2010 Completion: Aug 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Vascular Closure, this trial is completed. The trial is conducted by Access Pharmaceuticals, Inc. and has accumulated 8 data snapshots since 2009. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2023 — Jul 2024 [monthly]

Completed NA
Dec 2022 — Jan 2023 [monthly]

Completed NA
Dec 2021 — Dec 2022 [monthly]

Completed NA

▶ Show 3 earlier versions

Jan 2021 — Dec 2021 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Oct 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Access Pharmaceuticals, Inc.
University of Florida

Data source: University of Florida

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Gainesville, United States